*By Carlo Versano* On Tuesday, Missouri could become the 32nd state in the U.S. to legalize medical marijuana. On the ballot are three proposals on the issue ー regarding regulation, taxation, and the distribution of tax revenues. The amendments are byzantine and confusing, but if one passes, medical marijuana will become the law of the land in the "Show-Me" State. Cannabis legalization has garnered more public support in recent years, and medical pot is often thought to be the gateway to fuller legalization. While the Missouri medical community is [split](https://kcmedicine.org/survey-results-physician-attitudes-medical-marijuana/) on the drug's medicinal value, much of the student body at the University of Missouri has a pro-legalization stance. CheddarU went to Mizzou's campus to hear what students had to say ahead of the vote. "I just can't see any good reason not to have it medicinally available here," said In'lana Henderson, VP of Students for Sensible Drug Policy at Mizzou. "People think that it's very taboo here," she added. That possibility that Missouri, a reliably red state in the country's heartland, could pass a progressive drug law, gives some students hope that the end result could galvanize public support for cannabis legalization. "I think that if we can legalize it, it will help other states do that, too," freshman Payton Nichols-Pittman said. Or, as senior Meg Rogers put it: "It's just something that we don't need to make people feel bad for." She added: "It's just a plant."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More